This study aimed to explore the influence of organic anion transporting polypeptide1B1 (OATP1B1) genotype on pharmacokinetics, lipid lowering effect and lipid profiles after rosuvastatin administration.
Open, one arm, single sequence study for healthy volunteers are investigated. Thirty four subjects may be enrolled. Rosuvastatin are administered once a day for 21 days. Before and after rosuvastatin administration, PK, PD and lipid profiles are investigated.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
34
20 mg once daily for 21 days
Clinical Trials Center, Seoul National University Hospital
Seoul, South Korea
pharmacokinetic parameters(Tmax,Cmax,AUC) of rosuvastatin
Time frame: Day 21 0h, 1h, 2h, 3h, 4h, 5h, 8h, 12h, 24h
lipid panel(LDL,HDL,TG,Total cholesterol)
Time frame: Day 1 0h, Day 22 0h
lipid metabolites
Time frame: Day -1 0h, Day21 0h, 4h, 8h
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.